NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
Clinical Trials
20 trialsNCT05728632 2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3 Unknown
NCT05733026 2023-02-17
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
Ain Shams University
Unknown
NCT05454553 2022-11-29
EDIPE
Institut de cancérologie Strasbourg Europe
Phase NA Unknown
NCT05146843 2022-04-08
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
D'Or Institute for Research and Education
Phase NA Unknown
NCT05298072 2022-03-28
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
University Hospital, Essen
Unknown
NCT02236806 2022-02-01
SAFE
Azienda Ospedaliero-Universitaria Careggi
Phase 3 Unknown
NCT05040867 2021-09-10
Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients
GO fit Lab- Ingesport
Phase NA Unknown
NCT05019365 2021-08-24
Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy
University of Glasgow
Unknown
NCT04962425 2021-07-15
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Peking University Third Hospital
Unknown
NCT04961307 2021-07-14
Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab
Peking University Third Hospital
Unknown
NCT04429633 2020-06-12
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Samsung Medical Center
Phase NA Unknown
NCT04046315 2020-03-16
EARLY-CATCH
Radboud University Medical Center
Unknown
NCT03155802 2019-11-01
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Stony Brook University
Unknown
NCT02571894 2018-03-07
COBC
Karolinska University Hospital
Phase NA Unknown
NCT01022086 2017-07-12
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unity Health Toronto
Unknown
NCT02052102 2017-01-06
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
AHS Cancer Control Alberta
Phase 2 Unknown
NCT01016886 2016-02-09
MANTICORE
AHS Cancer Control Alberta
Phase 1/2 Unknown
NCT02101879 2014-05-02
Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes
Rambam Health Care Campus
Unknown
NCT01246856 2011-09-12
TOXTAC
Radboud University Medical Center
Unknown